| Glenn Stephen Prescod, MD | |
|
333 School St, Suite 301, Pawtucket, RI 02860 | |
| (401) 725-3600 | |
| (401) 728-8760 |
| Full Name | Glenn Stephen Prescod |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 30 Years |
| Location | 333 School St, Pawtucket, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336263102 | NPI | - | NPPES |
| 180040482 | Other | RI | RAILROAD MEDICARE |
| 0000022059 | Other | RI | BLUE SHIELD OF RHODE ISLAND |
| 0800693 | Other | RI | UNITED HEALTHCARE |
| 761405 | Other | RI | TUFTS HEALTH PLAN |
| 9020656 | Medicaid | RI | |
| 400075 | Other | RI | BLUE CHIP |
| 29732 | Other | RI | NEIGHBORHOOD HEALTH PLAN OF RI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 8767 (Rhode Island) | Primary |
| Entity Name | Lifespan Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407116643 PECOS PAC ID: 2567455082 Enrollment ID: O20121029000368 |
News Archive
Scientists at Luna's nanoWorks Division in Danville, VA, have been developing a portfolio of new candidates based on antioxidant nanomaterials which could lead to a platform technology for treating a wide range of diseases. "One of our new nanomedicine prototypes, after only two weeks of treatment, was found to increase the number of hair follicles fourfold in mice which are born genetically hairless," said Robert Lenk, President of Luna's nanoWorks Division.
Results of a Schering-Plough Corporation Phase II trial of SCH 530348, a novel oral thrombin receptor antagonist (TRA), were published today in The Lancet and demonstrated that the investigational antiplatelet compound met its primary endpoints of safety and tolerability.
Pro-Pharmaceuticals, Inc., a developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today reported its financial results for the first quarter, ended March 31, 2010.
All parents worry when their child is undergoing surgery and anesthesia. You might assume that children undergoing surgery would be much relieved to find Mom or Dad is there when they wake up—but that's not necessarily the case, according to a study in the April issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).
Wound Management Technologies, Inc. a rapidly growing provider of specialty medical products, announced today that its Resorbable Orthopedics operating subsidiary is moving toward productization of its patented orthopedic bone void fillers. The company currently anticipates products to be introduced in Q3 2010, to the bio-products market, estimated to be a multi-billion dollar international market.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Glenn Stephen Prescod, MD 333 School St, Suite 301, Pawtucket, RI 02860 Ph: (401) 725-3600 | Glenn Stephen Prescod, MD 333 School St, Suite 301, Pawtucket, RI 02860 Ph: (401) 725-3600 |
News Archive
Scientists at Luna's nanoWorks Division in Danville, VA, have been developing a portfolio of new candidates based on antioxidant nanomaterials which could lead to a platform technology for treating a wide range of diseases. "One of our new nanomedicine prototypes, after only two weeks of treatment, was found to increase the number of hair follicles fourfold in mice which are born genetically hairless," said Robert Lenk, President of Luna's nanoWorks Division.
Results of a Schering-Plough Corporation Phase II trial of SCH 530348, a novel oral thrombin receptor antagonist (TRA), were published today in The Lancet and demonstrated that the investigational antiplatelet compound met its primary endpoints of safety and tolerability.
Pro-Pharmaceuticals, Inc., a developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today reported its financial results for the first quarter, ended March 31, 2010.
All parents worry when their child is undergoing surgery and anesthesia. You might assume that children undergoing surgery would be much relieved to find Mom or Dad is there when they wake up—but that's not necessarily the case, according to a study in the April issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).
Wound Management Technologies, Inc. a rapidly growing provider of specialty medical products, announced today that its Resorbable Orthopedics operating subsidiary is moving toward productization of its patented orthopedic bone void fillers. The company currently anticipates products to be introduced in Q3 2010, to the bio-products market, estimated to be a multi-billion dollar international market.
› Verified 4 days ago
Lin Chou, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 465 East Ave, Pawtucket, RI 02860 Phone: 401-728-9350 Fax: 401-728-1320 | |
Alfred A Paul, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 465 East Ave, Pawtucket, RI 02860 Phone: 401-728-9350 Fax: 401-728-1320 |